Product Recalls in Wisconsin

Product recalls affecting Wisconsin — including food, drugs, consumer products, medical devices, and vehicles distributed to Wisconsin. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,662 recalls have been distributed to Wisconsin in the last 12 months.

52,482 total recalls
2,662 in last 12 months

Showing 1158111600 of 13,395 recalls

DrugFebruary 20, 2014· GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline

Recalled Item: Nicotine polacrilex lozenge Recalled by GlaxoSmithKline Consumer Healthcare;...

The Issue: Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugFebruary 20, 2014· GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline

Recalled Item: Nicotine polacrilex lozenge Recalled by GlaxoSmithKline Consumer Healthcare;...

The Issue: Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugFebruary 20, 2014· GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline

Recalled Item: Nicorette Lozenge and NicoDerm CQ Recalled by GlaxoSmithKline Consumer...

The Issue: Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugFebruary 20, 2014· GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline

Recalled Item: Nicotine polacrilex lozenge Recalled by GlaxoSmithKline Consumer Healthcare;...

The Issue: Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugFebruary 20, 2014· GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline

Recalled Item: Nicotine polacrilex lozenge Recalled by GlaxoSmithKline Consumer Healthcare;...

The Issue: Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugFebruary 20, 2014· GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline

Recalled Item: Nicotine polacrilex lozenge Recalled by GlaxoSmithKline Consumer Healthcare;...

The Issue: Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugFebruary 20, 2014· GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline

Recalled Item: Nicorette (nicotine polacrilex) Lozenges Mini Recalled by GlaxoSmithKline...

The Issue: Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugFebruary 20, 2014· GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline

Recalled Item: Nicorette (nicotine polacrilex) Lozenges Mini Recalled by GlaxoSmithKline...

The Issue: Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugFebruary 20, 2014· GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline

Recalled Item: Nicorette Lozenge Recalled by GlaxoSmithKline Consumer Healthcare;...

The Issue: Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugFebruary 20, 2014· GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline

Recalled Item: Nicotine polacrilex lozenge Recalled by GlaxoSmithKline Consumer Healthcare;...

The Issue: Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugFebruary 19, 2014· Gilead Sciences, Inc.

Recalled Item: Atripla (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil...

The Issue: Presence of Foreign Substance: Red Silicone Rubber Particulates are Present...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugFebruary 14, 2014· Agila Specialties Private Ltd.

Recalled Item: etomidate injection Recalled by Agila Specialties Private Ltd. Due to...

The Issue: Presence of Particulate Matter: Potential for small black particles to be...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 14, 2014· Ben Venue Laboratories Inc

Recalled Item: Acetylcysteine Solution Recalled by Ben Venue Laboratories Inc Due to...

The Issue: Presence of Particulate Matter: During a review of retain samples, the firm...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugFebruary 14, 2014· Legacy Pharmaceutical Packaging

Recalled Item: Fluoxetine Capsules Recalled by Legacy Pharmaceutical Packaging Due to...

The Issue: Chemical Contamination: The recalling firm received notice that their...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 14, 2014· Medisca Inc

Recalled Item: CITRULLINE (L) in 25 g Recalled by Medisca Inc Due to Labeling: Label...

The Issue: Labeling: Label Mix-Up: FDA tested samples of API from Medisca, labeled as...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugFebruary 13, 2014· Noven Pharmaceuticals, Inc.

Recalled Item: Daytrana (methylphenidate) transdermal system patch Recalled by Noven...

The Issue: Defective Delivery System: Out of Specification (OOS) results for the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 13, 2014· Noven Pharmaceuticals, Inc.

Recalled Item: Daytrana (methylphenidate) transdermal system patch Recalled by Noven...

The Issue: Defective Delivery System: Out of Specification (OOS) results for the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 12, 2014· Teva Pharmaceuticals USA

Recalled Item: Fluoxetine Capsules USP Recalled by Teva Pharmaceuticals USA Due to Chemical...

The Issue: Chemical Contamination: Recall due to a customer complaint trend regarding...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 12, 2014· Teva Pharmaceuticals USA

Recalled Item: Fluoxetine Capsules USP Recalled by Teva Pharmaceuticals USA Due to Chemical...

The Issue: Chemical Contamination: Recall due to a customer complaint trend regarding...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 11, 2014· Teva Pharmaceuticals USA

Recalled Item: QVAR¿ (beclomethasone dipropionate HFA) Recalled by Teva Pharmaceuticals USA...

The Issue: Failed Impurity/Degradation Specification; for 17-BMP at the 9 and 18 month...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund